0001214659-21-013288.txt : 20211216
0001214659-21-013288.hdr.sgml : 20211216
20211216170017
ACCESSION NUMBER: 0001214659-21-013288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211214
FILED AS OF DATE: 20211216
DATE AS OF CHANGE: 20211216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUSTAFSON MARK
CENTRAL INDEX KEY: 0001303996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 211498394
MAIL ADDRESS:
STREET 1: 10691 ROSECROFT CRESCENT
CITY: RICHMOND
STATE: A1
ZIP: V7A 2H9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
4
1
marketforms-54671.xml
PRIMARY DOCUMENT
X0306
4
2021-12-14
0001677077
Alzamend Neuro, Inc.
ALZN
0001303996
GUSTAFSON MARK
3802 SPECTRUM BOULEVARD, SUITE 112C
TAMPA
FL
33612
true
false
false
false
Common Stock
2021-12-14
4
S
false
20000
2.8543
D
30000
D
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8543. The range of sale prices on the transaction date was $2.85 to $2.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price
/s/ Mark Gustafson
2021-12-16